The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRBS.L Regulatory News (RBS)

  • There is currently no data for RBS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

2016 EBA EU-wide stress test results

1 Aug 2016 07:07

RNS Number : 7910F
Royal Bank of Scotland Group PLC
01 August 2016
 

The Royal Bank of Scotland Group plc

 

Statement on the publication of the 2016 EBA EU-wide stress test results

 

01 August 2016

 

The Royal Bank of Scotland Group plc ("RBS") notes the announcement made today by the European Banking Authority ("EBA") and the Prudential Regulation Authority ("PRA") regarding the results of the 2016 EBA EU-wide stress test.

 

The 2016 EBA EU-wide stress test does not contain a pass/fail threshold.

 

On a fully loaded Basel 3 basis, RBS's modelled Common Equity Tier 1 ("CET1") ratio under the adverse scenario was 8.1% as at 31 December 2018. The low point CET1 ratio under this scenario was 7.8% as at 31 December 2017.

 

RBS's modelled leverage ratio under the adverse scenario was 3.6% on a fully loaded Basel 3 basis and 4.2% under the PRA transitional definition for leverage ratio as at 31 December 2018. The low point leverage ratio under this scenario was 3.5% on a fully loaded Basel 3 basis as at 31 December 2016 and 4.2% under the PRA transitional definition as at 31 December 2017.

 

The cumulative impacts on modelled operating profit, impairments in the banking book and losses in the trading book under the adverse scenario over the three years to 31 December 2018 are shown in the table below.

 

Table 1 - EBA CET1 ratio stress test result under the Adverse scenario

 

Fully loaded

Basel 3

31 December 2015 published CET1 ratio

15.5%

(GBPm)

3-year cumulative net interest income

25,331

3-year cumulative gains on financial assets and liabilities held for trading or designated at fair value through profit and loss, net

1,197

3-year cumulative impairments on financial assets not measured at fair value through profit or loss

(7,916)

3-year cumulative profit / (loss) for the year(1)

(11,151)

CET1 capital

23,577

EBA calculated risk-weighted assets

291,624

Resulting EBA-calculated CET1 ratio in 2018

8.1%

(1) Including stressed conduct and litigation losses.

 

 

 

 

 

 

 

 

Table 2 - EBA leverage ratio stress test result under the adverse scenario

 

Fully loaded

Basel 3 basis

31 December 2015 published leverage ratio

5.6%

(GBPm)

Tier 1 capital

29,415

Total leverage ratio exposures

702,462

Resulting EBA-calculated leverage ratio in 2018

3.6%

Note: The EBA stress test results are based on hypothetical adverse and baseline macroeconomic scenarios and a common methodology developed by the EBA (including a static balance sheet) applied across all participating banks. Neither the baseline scenario nor the adverse scenario should in any way be construed as an RBS forecast or directly compared to other information prepared by RBS.

 

The EBA stress test results cannot be used to infer outcomes of the 2016 Bank of England ("BoE") stress tests for UK banks. There are key distinctions between the two regulatory stress tests, including a static balance sheet assumption for the EBA exercise therefore a number of initiatives such as balance sheet reduction (including asset sales and divestments), business growth and cost savings are not factored into the stress outcomes.

 

The EBA stress tests, like those run by the BoE, currently include substantial stressed conduct and litigation charges in the adverse scenario only, primarily in relation to US RMBS.

 

Commenting on the results, Ewen Stevenson, Chief Financial Officer, said:

 

"The EBA stress test results demonstrate our continued progress towards transforming the balance sheet to being safe and sustainable. Over recent years we have materially strengthened our CET1 ratio, substantially reduced our balance sheet and leverage, and continued to de-risk our asset exposures.

 

We are confident that in delivering our strategy, we will transform RBS into a low risk, resilient bank."

 

RBS will announce its 2016 Interim Results on Friday, 5th August 2016.

 

The detailed results of the stress test, as well as information on RBS exposures to central, regional and local governments in the European Economic Area, are available via the link below:

 

http://www.eba.europa.eu/risk-analysis-and-data/eu-wide-stress-testing/2016/results

 

For further information, please contact:

 

Investor Relations

Richard O'Connor

Head of Investor Relations

+44 (0) 20 7672 1758

 

RBS Media Relations

+44 (0) 131 523 4205

 

 

Forward Looking Statements

This announcement contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including those related to RBS and its subsidiaries' regulatory capital position, risk-weighted assets, impairment losses and credit exposures under certain specified scenarios. In addition, forward-looking statements may include, without limitation, statements typically containing words such as "intends", "expects", "anticipates", "targets", "plans", "estimates" and words of similar import. These statements concern or may affect future matters, such as RBS's future economic results, business plans and current strategies. Forward-looking statements are subject to a number of risks and uncertainties that might cause actual results and performance to differ materially from any expected future results or performance expressed or implied by the forward-looking statements. Factors that could cause or contribute to differences in current expectations include, but are not limited to, legislative, fiscal and regulatory developments, competitive conditions, technological developments, exchange rate fluctuations and general economic conditions. These and other factors, risks and uncertainties that may impact any forward-looking statement or RBS's actual results are discussed in RBS's UK Annual Report and materials filed with, or furnished to, the US Securities and Exchange Commission, including, but not limited to, RBS's Reports on Form 6-K and most recent Annual Report on Form 20-F. The forward-looking statements contained in this announcement speak only as of the date of this announcement and RBS does not assume or undertake any obligation or responsibility to update any of the forward-looking statements contained in this announcement, whether as a result of new information, future events or otherwise, except to the extent legally required.

ENDS

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCLIFEETTILIIR
Date   Source Headline
5th Nov 20184:21 pmRNSPublication of Suppl.Prospcts
2nd Nov 20185:25 pmRNSPublication of 2018 EBA EU-wide stress test result
2nd Nov 20182:10 pmRNSDirector/PDMR Shareholding
1st Nov 20187:00 amRNSUK intra-Group capital & liquidity arrangements
31st Oct 20182:38 pmRNSTotal Voting Rights
31st Oct 20187:00 amRNSDividend Declaration
30th Oct 20184:05 pmRNSDirector/PDMR Shareholding
29th Oct 20183:46 pmRNSDirector/PDMR Shareholding
26th Oct 20187:00 amRNSInterim Management Statement
9th Oct 20182:07 pmRNSForm 8.3 - CareTech Holdings
4th Oct 201812:43 pmRNSForm 8.3 - CareTech Holdings
4th Oct 201812:25 pmRNSBLOCK LISTING SIX MONTHLY RETURN
1st Oct 20183:00 pmRNSDirector/PDMR Shareholding
28th Sep 201812:32 pmRNSTotal Voting Rights
25th Sep 201811:23 amRNSPricing of USD Fixed Rate to Floating Rate Notes
25th Sep 20187:00 amRNSBofAML Annual Financial CEO Conference
24th Sep 20189:00 amRNSRBS Investor SeminarUK Personal & Business Banking
17th Sep 201812:05 pmRNSPublication of Final Terms
13th Sep 201812:25 pmRNSForm 8.3 - CareTech Holdings
13th Sep 20188:00 amRNSBarclays Global Financial Services Conference
3rd Sep 20186:00 pmRNSPublication of Final Terms
31st Aug 20184:42 pmRNSTotal Voting Rights
31st Aug 20184:15 pmRNSNatWest Markets N.V. Interim Results 2018
22nd Aug 20185:01 pmRNSDividend Declaration
21st Aug 20183:32 pmRNSPublication of Suppl.Prospcts
17th Aug 20187:00 amRNSDirectorate Change
15th Aug 20187:00 amRNSDeclaration of Interim Dividend
13th Aug 20189:00 amRNSUpdate on ring-fencing plans
3rd Aug 20182:25 pmRNSForm 8.3 - [CareTech Holdings]
3rd Aug 20187:00 amRNSHalf-year Report
31st Jul 20182:44 pmRNSUpdate on ring-fencing plans
31st Jul 201812:04 pmRNSTotal Voting Rights
26th Jul 201812:17 pmRNSForm 8.3 - CareTech Holdings PLC
23rd Jul 20182:10 pmRNSForm 8.3 - CareTech Holdings plc
17th Jul 201811:46 amRNSRBS welcomes credit ratings action by Moody's
16th Jul 20186:18 pmRNSAllotment and Issue of New Ordinary Shares
16th Jul 20184:18 pmRNSForm 8.3 - CareTech Holdings plc
2nd Jul 20182:47 pmRNSCapital reduction - notice of completion
29th Jun 201812:51 pmRNSTotal Voting Rights
27th Jun 20184:36 pmRNSHolding(s) in Company
25th Jun 201811:52 amRNSPublication of Final Terms
22nd Jun 20185:28 pmRNSPublication of Final Terms
21st Jun 201811:52 amRNSPricing of USD Dual-Tranche Notes
8th Jun 20189:23 amRNSTR-1 Notification of major shareholdings
7th Jun 20189:00 amRNSGoldman Sachs European Financials Conference
5th Jun 20187:00 amRNSDisposal of approximately 7.7% of RBS Group plc.
4th Jun 20184:36 pmRNSIntention to dispose of c7.7% of RBS Group plc.
31st May 20185:32 pmRNSTotal Voting Rights
31st May 20184:30 pmRNSRBS notes credit rating actions by Standard&Poor's
31st May 201812:07 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.